基于血小板计数的最佳苏尼提尼布剂量,适用于患有胃肠道筋瘤的老年患者
Hirotaka Suto1, Miyuki Kawamura2, Mitsunori Morita2
1Department of Medical Oncology, Hyogo Cancer Center, Akashi, Japan hirotaka.suto@hyogo-cc.jp.
In vivo (Athens, Greece)
|October 30, 2025
概括
根据血小板计数调整的低剂量苏尼替尼,在患有耐伊马替尼布的胃肠层瘤 (GIST) 的老年患者中显示出有望的毒性管理. 这种方法可以改善治疗结果并减少不良事件.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 老年医学 老年医学
背景情况:
- 苏尼蒂尼布是治疗胃肠道 stromal 瘤 (GIST) 的第二线治疗方法.
- 老年患者经常经历骨髓抑制和其他不良事件 (AE) 与sunitinib.
- 对于管理毒性,特别是老年人来说,最佳的sunitinib剂量表仍然没有定义.
研究的目的:
- 为了评估sunitinib在患有直肠GIST的老年患者的治疗疗效.
- 根据血小板计数评估sunitinib的毒性管理策略.
- 为了建立一个最佳的剂量表为sunitinib在imatinib耐药的GIST.
主要方法:
- 一个病例报告,一个83岁的男性患有直肠GIST,接受了sunitinib治疗.
- 苏尼蒂尼布的剂量根据患者的血小板和中性粒细胞数量进行调整.
- 使用二次回归建模来预测在sunitinib戒断期间血清变化.
- 为了验证预测模型,使用了leave-one-out交叉验证.
主要成果:
- 血小板计数预测模型表现出高准确度 (R2 = 0.86).
- 血小板计数的验证R2在0.42到0.88之间,表明可靠性.
- 中性粒细胞计数预测模型显示精度较低 (R2 = 0.28).
- 患者获得了部分反应,可控毒性,主要是甲状腺功能低下.
结论:
- 低剂量的sunitinib单疗法,根据血小板计数进行剂量调整,可以有效.
- 这一策略可能有助于管理对伊马替尼布耐药GIST的老年患者的毒性.
- 基于血液学参数的个性化sunitinib剂量提供了一个可行的治疗选择.
相关概念视频
01:15Drug Dosing: Geriatric Patients
217
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
217
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
202
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
202
01:11Renal Failure: Dose Adjustments
426
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
426
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
224
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
224
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
144
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
144
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
182
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
182